The authors have reviewed applications of novel technologies in the major stages of biosimilars development: process development, pharmacology, toxicology, and clinical trials, with an emphasis on recent regulatory requirements.
Zara Bukhari
Advertisement
Zara Bukhari is PhD scholar at the University of the Pacific, Stockton, CA. F
Articles by Zara Bukhari
Advertisement
Latest Updated Articles
Biosimilars Drug Development: Advances in Technologies from Molecule Design to Clinical TrialsPublished: August 7th 2024 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
2
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
3
Establishing Risk Assessments for AI in Bio-Manufacturing
4
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
5
